Hemato- Oncology Care in COVID-19 Pandemic: Crisis within a Crisis.

Hemato- Oncology Care in COVID-19 Pandemic: Crisis within a Crisis. Asian Pac J Cancer Prev. 2020 May 01;21(5):1173-1175 Authors: Seth T, Shankar A, Roy S, Saini D PMID: 32458618 [PubMed - in process]
Source: Asian Pacific Journal of Cancer Prevention - Category: Cancer & Oncology Tags: Asian Pac J Cancer Prev Source Type: research

Related Links:

Conclusion: People with co-morbid conditions who are more prone to COVID-19-related deaths due to immune dysregulation are likely to benefit from consuming nutritional supplements that enhance the immune system. We recommend clinical studies to validate AFO-202 beta glucan in COVID-19 patients to prove its efficacy in overcoming a hyper-inflammation status, thus reducing the mortality, until a definite vaccine is made available.
Source: Frontiers in Immunology - Category: Allergy & Immunology Source Type: research
British Journal of Cancer, Published online: 08 July 2020; doi:10.1038/s41416-020-0980-xConsiderations for the treatment of pancreatic cancer during the COVID-19 pandemic: the UK consensus position
Source: British Journal of Cancer - Category: Cancer & Oncology Authors: Source Type: research
We describe the outcomes in cancer patients during the initial outbreak of the COVID-19 in Europe from the retrospective, multi-center observational OnCovid study. We identified 204 cancer patients from eight centers in the United Kingdom, Italy, and Spain aged > 18 (mean = 69) and diagnosed with COVID-19 between February 26th and April 1st, 2020. A total of 127 (62%) were male, 184 (91%) had a diagnosis of solid malignancy, and 103 (51%) had non-metastatic disease. A total of 161 (79%) had > 1 co-morbidity. A total of 141 (69%) patients had > 1 COVID-19 complication. A total of 36 (19%) were escalated...
Source: Cancers - Category: Cancer & Oncology Authors: Tags: Article Source Type: research
Source: Clinical Oncology - Category: Radiology Authors: Tags: Letter Source Type: research
One in four UK GPs say rising numbers of cancer referrals have been rejected inappropriately during the COVID-19 pandemic, amid concerns that thousands of cases of cancer may have been missed.
Source: GP Online News - Category: Primary Care Tags: Coronavirus Source Type: news
Authors: Mjaess G, Karam A, Aoun F, Albisinni S, Roumeguère T Abstract COVID-19 is the pandemic that hit the world starting December 2019. Recent studies and international statistics have shown an increased prevalence, morbidity as well as mortality of this disease in male patients compared to female patients. The aim of this brief communication is to describe the pathophysiology of this sex-discrepancy, based on the infectivity mechanism of the coronavirus including the Angiotensin-Converting Enzyme 2 (ACE2), the Type II transmembrane Serine Protease (TMPRSS2), and the androgen receptor. This could help und...
Source: Progres en Urologie - Category: Urology & Nephrology Tags: Prog Urol Source Type: research
(Beth Israel Deaconess Medical Center) Early in the COVID-19 pandemic, widespread cancellations of electively-scheduled or " non-emergency " operations were implemented to free up hospital beds and conserve protective equipment for health care workers. In a new study published in the Journal of Gastrointestinal Surgery, a team of investigators at Beth Israel Deaconess Medical Center examined the effects of delaying surgery for gastrointestinal cancers.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news
In light of the coronavirus disease 2019 (COVID-19) pandemic, cancer centres in the United Kingdom and Europe re-organised their services at an unprecedented pace, and many patients with cancer have had their treatments severely disrupted. Patients with cancer were considered at high risk on sparse evidence, and despite a small number of emerging observational studies, the true incidence and impact of COVID-19 in the ‘at-risk’ population of patients with cancer is yet to be defined.
Source: European Journal of Cancer - Category: Cancer & Oncology Authors: Tags: Original Research Source Type: research
The coronavirus disease (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has spread exponentially worldwide. In Brazil, the number of infected people diagnosed has been increasing and, as in other countries, it has been associated with a high risk of contamination in healthcare teams. For healthcare professionals, the full use of personal protective equipment (PPE) is mandatory, such as wearing surgical or filtering facepiece class 2 (FFP2) masks, waterproof aprons, gloves, and goggles, in addition to training in care processes. A reduction in the number of face-to-face visits an...
Source: Clinics - Category: General Medicine Source Type: research
The coronavirus disease (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has spread exponentially worldwide. In Brazil, the number of infected people diagnosed has been increasing and, as in other countries, it has been associated with a high risk of contamination in healthcare teams. For healthcare professionals, the full use of personal protective equipment (PPE) is mandatory, such as wearing surgical or filtering facepiece class 2 (FFP2) masks, waterproof aprons, gloves, and goggles, in addition to training in care processes. A reduction in the number of face-to-face visits an...
Source: Clinics - Category: General Medicine Source Type: research
More News: Cancer | Cancer & Oncology | COVID-19 | Pandemics